Check out the firms making headlines noon on Monday:
Nikola — Shares of the electric-vehicle maker rose practically 6% after a JPMorgan analyst stated he sees a "less drama-filled" information movement for the firm in 2021. "We expect Nikola to post a video of a functioning Tre in January. We look for a steady flow of updates for the truck in 2021, as test milestones are met," the analyst stated.
Myovant Sciences — Shares rose 25% after the firm agreed to a collaboration with Pfizer to develop prostate most cancers drug relugolix. The drug can also be being explored for doable use in girls's well being.
Weibo — The inventory dropped more than 10% regardless of a better-than-expected quarterly report from the Chinese social media firm. Weibo posted adjusted revenue of 66 cents per share, 6 cents above Refinitiv estimates. Its income additionally got here in above analyst forecasts. Some analysts flagged the slowdown in the firm's development in common lively each day customers, nevertheless.
Astrazeneca — U.S.-listed shares of the drug maker gained more than 1% after a number of reviews stated that the firm's Covid vaccine, which was developed in partnership with Oxford University, is predicted to be accepted in the U.Okay. this week. The AstraZeneca shot would probably be rolled out subsequent week if accepted in the subsequent few days.
Apple — Shares of the tech big superior more than 3% amid power in Big Tech. The advance comes after Apple posted its fourth straight week of positive factors.
Novavax — Shares dipped more than 2% after the biotechnology firm stated its coronavirus vaccine candidate entered a Phase 3 trial in the U.S. and Mexico. "This trial is a critical step in building the global portfolio of safe and effective vaccines to protect the world's population," stated CEO Stanley Erck in a press release.
DoorDash — The meals supply firm fell 3.8% after a Wall Street Journal column highlighted how a brand new invoice in California might damage supply providers. The regulation would require companies to have said agreements with eating places, probably hurting the development technique for some providers.
CNBC's Pippa Stevens, Jesse Pound and Yun Li contributed to this report.
primarily based on web site supplies www.cnbc.com